AEMD vs ABT: Which Stock is Better?
Side-by-side comparison of Aethlon Medical Inc and Abbott Laboratories in 2026
AEMD
Aethlon Medical Inc
$2.02
ABT
Abbott Laboratories
$91.30
Key Metrics Comparison
| Metric | AEMD | ABT | Winner |
|---|---|---|---|
| Market Cap | $3.34M | $158.12B | ABT |
| P/E Ratio | N/A | 25.43 | ABT |
| EPS (TTM) | $N/A | $3.57 | ABT |
| Revenue Growth | 42.8% | 0.1% | AEMD |
| Gross Margin | 100.0% | 56.5% | AEMD |
Analyze AEMD
Full quant analysis
Analyze ABT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is AEMD or ABT a better investment?
Comparing AEMD and ABT: Aethlon Medical Inc has a market cap of $3.34M while Abbott Laboratories has $158.12B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between AEMD and ABT?
AEMD (Aethlon Medical Inc) and ABT (Abbott Laboratories) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: AEMD or ABT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: AEMD or ABT?
AEMD has higher revenue growth at 42.8% vs 0.1% for ABT.
Which company is more profitable: AEMD or ABT?
Aethlon Medical Inc (AEMD) has higher gross margins at 100.0% compared to 56.5% for ABT.
Which is the larger company: AEMD or ABT?
Abbott Laboratories (ABT) is larger with a market cap of $158.12B compared to $3.34M for AEMD.
Should I buy AEMD or ABT in 2026?
Both AEMD and ABT have investment merit. AEMD trades at $2.02 while ABT trades at $91.30. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between AEMD and ABT stock?
Key differences: Market Cap ($3.34M vs $158.12B), P/E Ratio (N/A vs 25.4x), Revenue Growth (42.8% vs 0.1%), Gross Margin (100.0% vs 56.5%).
Should I buy AEMD or ABT in 2026?
The choice between AEMD and ABT depends on your investment goals. AEMD shows higher revenue growth (42.8%). AEMD has better margins (100.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between AEMD and ABT?
AEMD (Aethlon Medical Inc) has a market cap of $3.34M, while ABT (Abbott Laboratories) has a market cap of $158.12B. ABT is the larger company by market value.